chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (is very "nasely" and her nose is really stuffed.), SNEEZING (has been sneezing a lot), FEELING HOT (on Thursday night, patient experienced body aches, chills and was hot but doesn't remember having a fever), RASH (rash on my face/rash in forehead around my eyes) and CHILLS (on Thursday night, patient experienced body aches, chills and was hot but doesn't remember having a fever) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032H21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Previously administered products included for Product used for unknown indication: JandJ (first shot given in right dominant arm with lot number :1802070) on 14-Mar-2021.Past adverse reactions to the above products included No adverse event with JandJ. On 08-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Dec-2021, the patient experienced FEELING HOT (on Thursday night, patient experienced body aches, chills and was hot but doesn't remember having a fever), CHILLS (on Thursday night, patient experienced body aches, chills and was hot but doesn't remember having a fever) and MYALGIA (on Thursday night, patient experienced body aches). On an unknown date, the patient experienced NASAL CONGESTION (is very "nasely" and her nose is really stuffed.), SNEEZING (has been sneezing a lot) and RASH (rash on my face/rash in forehead around my eyes). The patient was treated with NAPROXEN SODIUM (ALEVE) for Adverse event, at an unspecified dose and frequency. On 10-Dec-2021, FEELING HOT (on Thursday night, patient experienced body aches, chills and was hot but doesn't remember having a fever), CHILLS (on Thursday night, patient experienced body aches, chills and was hot but doesn't remember having a fever) and MYALGIA (on Thursday night, patient experienced body aches) had resolved. At the time of the report, NASAL CONGESTION (is very "nasely" and her nose is really stuffed.), SNEEZING (has been sneezing a lot) and RASH (rash on my face/rash in forehead around my eyes) outcome was unknown. Concomitant medications were not provided. Treatment medication also includes sinus medication and antihistamine.
Swollen feet Hand and face 2 hours after shots. Broke out in Hives. Mom gave Atarax. No breathing difficulties noted.
The following symptoms less than 24 hours after injection, all over aching an tingling, headache, fever and local reaction.
Within four days of the first shot I started getting a blistering rash on the side of my right leg that then became worse, inflamed, had burning sensations which eventually started shooting down my leg to my ankle and also up through my butt muscles area. I went to urgent care today and they verified it was shingles I am now on anti viral medication.
Patient received the vaccine on  4/11/23 around 13:30. He came back to the pharmacy this afternoon about 15:00 and showed his arm was red and swollen from the elbow up. We recommended he go upstairs to see his PCP and he did. Not sure of the outcomes of that visit.
arm pain; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number/expiration date unknown), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported. On an unspecified date, after use of the product, the patient experienced a lot of arm pain. The outcome of the event was unknown.  No follow-up attempts are possible; information about batch/ lot number cannot be obtained.
Patient has a rash on her right upper arm that stretches from just under shoulder to about 4 inches above elbow and is about 3 inches wide at the widest point (6in X 3in). Pt has used diphenhydramine and ibuprofen for the itchiness and the pain associated with the rash. Pt stated that this started the day after the vaccine was given and reported to me 2 days post vaccine.
Left sided Migraine that lasted 3 days. I took BC powder, Excedrin, and my regular prescribed migraine meds. Nothing helped, it was relentless. I am still having some pain but not as severe. I did not seek treatment as I hate the shots they used to do before my Topamax was prescribed. I had been migraine free for a little over year before this shot.
Rare side effects; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Rare side effects) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Rare side effects). At the time of the report, VACCINATION COMPLICATION (Rare side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported No treatment medication was reported
Induration, redness, itching, pain. Maximal pain, redness, and induration: 9/30/12, 3:00PM, approx 3.5 cm diameter.
This spontaneous report was received from an office manager concerning an unknown number of patients of unknown ages and genders. The patients' medical history, concurrent conditions and concomitant medications were not reported. On unknown dates, the patients were vaccinated with doses of PNEUMOVAX 23, for prophylaxis (dose number, route and anatomical location of administration, lot number and expiration date were not reported). The doses were stored between 32 to 35 Fahrenheit degrees for 120 hours, and 31 Fahrenheit degrees for 216 hours. There was no previous temperature excursion nor data logger involved. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1705USA004190: US-009507513-1705USA004191: US-009507513-1705USA004192: US-009507513-1705USA004094: US-009507513-1705USA004194.
A 21 year old female pt experienced fever and vomiting after pre exposure vaccination with RabAvert. The pt received RabAvert IM on 04Aug04 and 11Aug04. Her allergies included sulfa and raspberries. Her past medical history and concomitant medications were unspecified. Approx 24 hours after receiving RabAvert on 11Aug04, the pt complained of 2 episodes of vomiting and a fever of 101.2F that persisted for 12 to 24 hours. No further details were provided.
Anxiety; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 15-Mar-2021 and was forwarded to Moderna on 16-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (Anxiety) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included SERTRALINE HYDROCHLORIDE (ZOLOFT) for an unknown indication.    On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced ANXIETY (Anxiety). At the time of the report, ANXIETY (Anxiety) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient had stopped taking few doses of Zoloft as he was concerned the medication might reduce the response of vaccine. No treatment medication information was provided
1:00 AM: Severe chills, weakness of body. Two hours later, 3:00 AM, 102 grade fever.
pt recvd vax; exp t of 100.5 after few hrs;very red eyes for 24 hrs; had blurred vision because of mucous & a very grainy feeling in my eyes; mild soreness in inject site;next day, eyes still red but much milder; conjunctival, eyes hurted ;
4/18/2022-Presents to ED, c/o SOB. Tachy at 138, O2 sat 89% on 4L, placed on Bipap. Covid + on admission. CXR-bibasilar infiltrates. Transaminits: AST 154  ALT 129.  D Dimer 848. Start Remdesivir. Admit COPD exacerbaton in the setting of Covid 19.  4/20/2022-Transmanitis improving.  Currently on RA. 4/22/2022- Weaned to RA. Improved AST 55 and ALT 104. D/C to home.
I woke up in the night with severe indigestion, a pain in my left jaw and pain in the back of my ribs near my heart. It?s subsided in about one minute time. This morning I woke up with some right arm pain but it was short-lived too. I have felt fine since...
Patient received the two immunizations listed above on 10/2/2017, in the left arm separated roughly 2 inches apart. Patient woke up the following morning with a 103 degree fever and hive like reaction on his left arm. Patient went to the hospital for medical attention on 10/3/2017. After several days, his fever finally broke and the swelling and redness on his arm began to subside. Patient's wife then came in to the pharmacy on 10/13/2017 to describe his reactions.
"Covid Arm" developed a week after the first vaccine. The site is red and warm with a slight bit on tingling.
This spontaneous report was received from a healthcare worker refers to a multiple patients of unknown age and gender. No pertinent medical history was reported. Since 28-JUL-2014, the patients were vaccinated with MMR II (dose, route, lot# were not reported) after being improperly stored. No adverse effects were reported. No Product Quality Complaint (PQC) was involved. This is one of several reports from the same source. Additional information has been requested.
neurological grand mal seizures; difficulty breathing; tight chest; sore achy bones, muscle; sore achy bones, muscle; This is a spontaneous report received from a contactable consumer (patient). A 54-year-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: ER8737), via an unspecified route of administration at the left arm on 27Mar2021 12:45 pm at single dose for COVID-19 immunization. The patient's medical history included juvenile rheumatoid arthritis, asthma, diabetic Type 2, neurological seizure disorder from traumatic brain injury. The patient had known allergies to penicillin, tetracycline, sulfonamide. Concomitant medications included methotrexate (withheld for 2 weeks 25mg injection). On 28Mar2021 1:15 AM, the patient experienced neurological grand mal seizures, sore achy bones, muscle, tight chest, and difficulty breathing. The patient was treated with nebulizer for difficulty breathing. It was reported that patient had no covid prior vaccination nor tested post vaccination. Outcome of events was reported as not recovered.
This is a spontaneous report from a contactable consumer who reported the same events for herself and for her mother. This is the second of two reports (reporter's mother case). A female patient of unspecified age received a single dose of PREVNAR 13, in arm on an unspecified date for immunisation. The patient medical history was not reported. Concomitant medication included influenza vaccine (FLU SHOT) given on the other arm for immunisation.  Since an unknown date, the patient lost her appetite (she did not eat from 1 o'clock in the afternoon until 7 of the day after) and it was hard to sleep for her. The outcome of the events was unknown. Sender's Comments: Linked Report(s) : US-PFIZER INC-2016509473 different patient same drug/event.
Arm is sore where injection happened. Later in the day after the injection I got chills and feverish. Had nausea and body aches all night and through to the next morning. Also experiencing diarrhea and dry mouth.
My COVID-19 infection symptoms started on 12/26/2022. I wasn't feeling well so I took a home COVID-19 test before going to work and it was negative. I had slight fever, felt achy and tired. Then I took another home test on 12/27/2022 which was positive. I had fever, tiredness, and cough. On 12/28/2022 my symptoms got worse. On 12/29/2022 symptoms stayed the same and I called my doctor's office where I did telehealth. They prescribed me PAXLOVID for 5 days. I also took TYLENOL for fever.
contracted SARS-COV-2; contracted SARS-COV-2; This is a spontaneous report from a contactable physician (patient) via Medical Information. This physician reported similar events for two patients. This is the first of two reports.   A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date were not reported), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported that she received her first COVID-19 vaccination but contracted SARS-COV-2 from her husband, seven days after vaccination. Outcome of the events was unknown.   Information about batch/lot number is requested.; Sender's Comments: Comirnaty's effectiveness is documented after at least seven days from the second vaccination.,Linked Report(s) : US-PFIZER INC-2021036192 same reporter/drug/events, different patients
5 months after the second vaccination my menstrual period dropped 3 times in less than 30 days. The first two periods only lasted 1 day, a week apart. The third time my period lasted 2 days.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 10-DEC-2015 at 16:00, the patient was vaccinated with improperly stored RECOMBIVAX HB with lot number: L025738, expiry date: unspecified (dose and strength unspecified). No concomitant medications were reported. No adverse effect were reported. The high and low temperature were 6.4 and 5.9 (units unspecified) respectively. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Dizziness, light-headedness, body aches, nausea, vomiting, and headache
Around 12 hours after time of vaccine dose until 28 hours post-vaccine, I felt very nauseous, had intense body aches, chills, shivering, body weakness, rapid heart rate (around 120), decreased O2 sat (around 90), and difficulty breathing. Symptoms came on very suddenly (around 10pm on the day of the vaccine) and ended very suddenly (around 2pm the next day). Body was still weak once recovered.
This spontaneous report as received from a medical assistant refers to a 18 year old patient of unknown gender. The patient's drug allergies and pertinent medical history was not reported. On 23-JUN-2014 the patient was vaccinated with first dose of VAQTA (dose, frequency and route of administration were not reported) (lot # J005010, expiry date: 23-OCT-2014) which was stored improperly. No adverse effects were noted. No product quality complaint was reported for VAQTA. Addtional information has been requested.
Increased frequency in migraines (increased from 1 per 6 months to over 3 events weekly). Vaginal spotting outside of menstrual cycle. (Continual spotting that has not stopped since vaccine).
Had vaccine 9:00 am, by 2 pm husband was feeling  ill, with tiredness, muscle pain, headache, shivering fever, nausea and moderate pain and soreness at vaccination site on left arm. Symptoms persisted through the night, night seats and achy muscles. Felt very weak and shivering!
First vaccine administered on 14-Jan-2021 and second on 17-Jan-2021; cough; Shortness of breath; wheezing; This spontaneous case was reported by a physician and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First vaccine administered on 14-Jan-2021 and second on 17-Jan-2021), COUGH (cough), DYSPNOEA (Shortness of breath) and WHEEZING (wheezing) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Ankylosing spondylitis.    No Medical History information was reported.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. In January 2021, the patient experienced COUGH (cough), DYSPNOEA (Shortness of breath) and WHEEZING (wheezing). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First vaccine administered on 14-Jan-2021 and second on 17-Jan-2021). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First vaccine administered on 14-Jan-2021 and second on 17-Jan-2021) had resolved and COUGH (cough), DYSPNOEA (Shortness of breath) and WHEEZING (wheezing) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications and treatment information was not provided.
SARS-COV 2 PCR test positive; SARS-COV 2 PCR test positive; This is a literature report.  A 55-year-old male patient received COVID-19 Vaccine - Manufacturer Unknown, as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "recovered" and all described as "SARS-COV 2 PCR test positive". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: 17.2, notes: Day 12; 22.9, notes: Day 14; 22.9, notes: day 16. Therapeutic measures were taken as a result of covid-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: As there is limited information in the case provided, the causal association between the events and the suspect drug cannot be excluded. The case will be reassessed once new information is available,Linked Report(s) : DE-PFIZER INC-202200740728 Same article, other patient (1)
barely soreness; all the liquid from the needle ran down arm; all the liquid from the needle ran down arm; A spontaneous report was received from a consumer concerning a 59-year-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and liquid from the needle ran down her arm and experienced barely soreness.   The patient's medical history was not provided. Products known to have been used by the patient, within two weeks prior to the event, included atorvastatin 10 mg, amlodipine 2.5 mg, acidophilus, vit D, aspirin, and coQ10.    On 26 Jan 2021, the patient received their first of two planned doses of mRNA-1273 (Batch number not provided) intramuscularly for prophylaxis of COVID-19 infection.   Patient stated that she had her 1st dose of the Moderna Covid-19 vaccine 26 Jan 2021 and felt all the liquid drip down her arm. She was sure if she got anything from the "1st" dose. She felt the needle go in, barely experienced soreness for that day. Treatment information was not provided.    Action taken with the drug in response to the events is unknown.  The outcome of the event barely soreness was resolved on 26 Jan 2021. The event vaccine underdose and device connection issue was considered resolved on 26 Jan 2021.; Reporter's Comments: Based on the current information and temporal association between the use of the product and the start date of soreness, a causal relationship cannot be excluded. The causality of events of vaccine underdose and device connection is not applicable.
Stomach pain; COVID-19; Numbness in face; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach pain), COVID-19 (COVID-19) and HYPOAESTHESIA (Numbness in face) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    No Medical History information was reported.   On 01-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On 01-Jun-2021, the patient experienced HYPOAESTHESIA (Numbness in face). On an unknown date, the patient experienced ABDOMINAL PAIN UPPER (Stomach pain) and COVID-19 (COVID-19). On 01-Jun-2021, HYPOAESTHESIA (Numbness in face) had resolved. At the time of the report, ABDOMINAL PAIN UPPER (Stomach pain) and COVID-19 (COVID-19) had resolved.            Concomitant Medication use information was not provided by reporter.  It was unknown if patient was enrolled in a covid-19 vaccine trial.   The reporter's causality for the event(s) of second vaccine caused face to numb, had covid and stomach pain was not provided.  Treatment Medication use information was not provided by reporter.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
Immunizations 8/11/11, 8/13/11 RT leg - thigh to knee swollen 2x normal with heat & redness. Temp 101.5, pain. ED visit treated with BENADRYL q 4 hours. Resolving today 8/15/11.
This spontaneous report as received from a Licensed Practical Nurse refers to a 4 month old male patient. No information on patient's medical history, concurrent conditions and concomitant medications was provided. On an unknown date in 2017, the patient was vaccinated with the first dose of ROTATEQ, oral (dose, lot #, expiry date were not provided) for the prevention of rotavirus gastroenteritis and it was well tolerated. On 22-JUN-2017, the patient was vaccinated with the second dose of ROTATEQ lot # M044395, expiry date: 31-MAY-2018 and vomited immediately afterward. The patient did not receive any treatment. No further adverse effects and no product quality issue were reported. The outcome of vomiting was unknown. Causality assessment was not provided. Additional information has been requested.
Localised numbness; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Localised numbness) and FATIGUE (Tiredness) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (Localised numbness) and FATIGUE (Tiredness). At the time of the report, HYPOAESTHESIA (Localised numbness) and FATIGUE (Tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The concomitant medications were not reported.  The treatment information was not provided.   This case was linked to MOD-2021-221132 (Patient Link).